3B

3billion Inc.

AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.

394800 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로 415 8층(삼성동, 엘7호텔스강남타워), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

3billion Inc. is a biotechnology company specializing in AI-driven genetic diagnostics for rare diseases. The company aims to end the "diagnostic odyssey" for patients by providing fast, accurate, and comprehensive testing solutions. Leveraging its artificial intelligence platform, 3billion analyzes over 20,000 genes through services like whole-exome (3B-EXOME) and whole-genome sequencing. A key differentiator is its commitment to unlimited reanalysis, which re-evaluates patient data against new scientific discoveries to increase diagnostic yield over time. 3billion collaborates with a global network of over 700 institutions and 1,600 healthcare providers across more than 70 countries to make its one-stop diagnostic services accessible to patients with suspected rare diseases.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for 3billion Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all 3billion Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for 3billion Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Delta-Fly Pharma, Inc. Logo
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
Japan 4598
DENTSU GROUP INC. Logo
Global advertising & marketing firm integrating tech and consulting for brand growth.
Japan 4324
DGA S.A. Logo
Consulting, training, and EU-funded project services for public and private organizations.
Poland DGA
DIGITAL HOLDINGS,INC. Logo
Drives business DX with data-driven advertising, CRM consulting, and AI integration.
Japan 2389
DIGITALIFT Inc. Logo
Digital marketing firm providing programmatic ad operations and strategic consulting services.
Japan 9244
D.L.S.I. Logo
HR and recruitment services for temp, fixed-term, and permanent roles across industries.
France ALDLS
Investment firm leasing four Airbus A380s to Emirates for shareholder returns.
Guernsey N/A
Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.
Guernsey N/A
DreamCIS INC. Logo
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea 223250
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930

Talk to a Data Expert

Have a question? We'll get back to you promptly.